Not Tagged
janssen
['biomarker', 'nsclc', 'sclc', 'janssen']
alterations in the egfr gene are one of the most common drivers for nsclc. biomarker testing for actionable genes may optimise treatment recommendations and health outcomes for patients. watch to learn more.
#asco23 #oncology 
We are Janssen EMEA, the Pharmaceutical Companies of Johnson & Johnson. Find out how to contact us here: https://t.co/fjeepRP4O3